정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
---|---|---|---|---|---|---|---|---|---|---|---|
2165 | Not yet recruiting | Arformoterol/Budesonide for COVID-19 | Coronavirus Infection | Drug: UI030 | Phase 2 | Korea United Pharm. Inc. | INDUSTRY | 140 | All | 19 Years | |
2164 | Withdrawn | ASC Therapy for Patients With Severe Respiratory COVID-19 | Respiratory Tract Diseases | Drug: Stem Cell Product | Phase 2 | Rigshospitalet, Denmark | OTHER | 0 | All | 18 Years ~ 80 Years | 2014 Department of Cardiology, The Heart Centre, University Hospital Rigshospitalet, Copenhagen, Denmark |
2163 | Completed | Ascending Dose Study of Investigational SARS-CoV-2 Vaccine ARCT-021 in Healthy Adult Subjects | SARS-CoV-2 | Biological: ARCT-021 Dose 1 Biological: ARCT-021 Dose 2 Biological: ARCT-021 Dose 3 Biological: ARCT-021 Dose 4 Biological: ARCT-021 Dose Regimen 1 Biological: ARCT-021 Dose Regimen 2 Other: Placebo |
Phase 2 | Arcturus Therapeutics, Inc. | INDUSTRY | 106 | All | 21 Years ~ 80 Years | SingHealth Investigational Medicine Unit (IMU), Singapore General Hospital, Singapore, Singapore |
2162 | Active, not recruiting | Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications | COVID 19 | Drug: Convalescent Plasma Other: Standard Care Therapy |
Phase 2 | Max Healthcare Insititute Limited | OTHER | 100 | All | 18 Years ~ 85 Years | Max Super Speciality hospital, Saket (A unit of Devki Devi Foundation), New Delhi, Delhi, India |
2161 | Recruiting | Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in Thailand | Covid-19 Vaccine | Biological: Normal Saline Biological: NDV-HXP-S vaccine |
Phase 2 | Mahidol University, The Government Pharmaceutical Organization | OTHER | 460 | All | 18 Years ~ 75 Years | Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand |
2160 | Withdrawn | Assessing Hydroxychloroquine in Patients With SARS-CoV-2 (COVID-19) | SARS-CoV-2 | Drug: Hydroxychloroquine Drug: Placebo |
Phase 2 | Oregon Health and Science University, OHSU Knight Cancer Institute | OTHER | 0 | All | 18 Years | Oregon Health and Science University, Portland, Oregon, United States |
2159 | Recruiting | Assessing Safety, Hospitalization and Efficacy of rNAPc2 in COVID-19 | Covid19 | Drug: rNAPc2 Drug: Heparin |
Phase 3 | ARCA Biopharma, Inc., Colorado Prevention Center | INDUSTRY | 160 | All | 18 Years ~ 90 Years | ARCA Investigational Site #119, Fairhope, Alabama, United States ARCA Investigational Site #118, Phoenix, Arizona, United States ARCA Investigational Site #120, Tucson, Arizona, United States ARCA Investigational Site #104, Aurora, Colorado, United States ARCA Investigational Site #117, Denver, Colorado, United States ARCA Investigational Site #101, Jacksonville, Florida, United States ARCA Investigational Site #128, Evanston, Illinois, United States ARCA Investigational Site #113, New Orleans, Louisiana, United States ARCA Investigational Site #105, Falls Church, Virginia, United States ARCA Investigational Site #114, Richmond, Virginia, United States ARCA Investigational Site #103, Tacoma, Washington, United States ARCA Investigational Site #127, San Nicolas, Buenos Aires, Argentina ARCA Investigational Site #130, Rosario, Santa Fe, Argentina ARCA Investigational Site #112, Rosario, Sante Fe, Argentina ARCA Investigational Site #111, Buenos Aires, Argentina ARCA Investigational Site #115, Caba, Argentina ARCA Investigational Site #126, Cordoba, Argentina ARCA Investigational Site #129, San Miguel de Tucuman, Argentina ARCA Investigational Site #106, San Miguel De Tucuman, Argentina ARCA Investigational Site #125, Campo Grande, Mato Grosso Do Sul, Brazil ARCA Investigational Site #124, Braganca Paulista, Sao Paolo, Brazil ARCA Investigational Site #122, Sao Jose do Rio Preto, Sao Paolo, Brazil ARCA Investigational Site #123, Porto Alegre, Brazil ARCA Investigational Site #121, Sao Paulo, Brazil |